Athersys

Athersys is a clinical-stage biotechnology company that  has established a pipeline of therapeutic product development programs in multiple disease indications. The company’s product portfolio consists of MultiStem, a non-embryonic stem cell-based approach for treating disease indications in the areas of inflammatory and immune, neurological and cardiovascular disease.

 

 

Athersys

Cleveland, OH

Website

NASDAQ

ATHX

09.28.2016
Athersys Receives FDA Agreement Under Special Protocol Assessment…

Read More

02.17.2016
One-Year Results From Phase 2 Stroke Study of MultiStem® Cell Th…

Read More